American Academy of Ophthalmology Integrates Clinical Guidelines into OpenEvidence AI Platform

Event summary

  • The American Academy of Ophthalmology (AAO) and OpenEvidence have partnered to integrate AAO’s clinical guidelines into OpenEvidence’s AI platform.
  • AAO’s Preferred Practice Patterns® and Ophthalmic Technology Assessments will be directly accessible to ophthalmologists via OpenEvidence at no cost.
  • The partnership includes a feedback loop where OpenEvidence provides AAO with usage data to identify gaps in clinical guidance.
  • AAO maintains full intellectual and financial responsibility for its content under the licensing agreement.

The big picture

This partnership marks a strategic shift in how clinical guidelines are delivered to physicians, leveraging AI to bridge the gap between evidence-based medicine and real-world practice. The integration of AAO’s authoritative content into OpenEvidence’s platform could set a new standard for how medical associations distribute and refine their guidance. The deal underscores the growing role of AI in enhancing clinical decision-making, particularly in specialized fields like ophthalmology where evidence review is deeply nuanced.

What we're watching

Adoption Dynamics
How quickly ophthalmologists will integrate AAO’s guidelines into their workflows via OpenEvidence’s platform.
Content Evolution
Whether the feedback loop will lead to more targeted updates of AAO’s clinical guidelines.
Competitive Positioning
The pace at which OpenEvidence can expand similar partnerships with other medical associations.

Related topics

Partnership